Immunotherapy approach offers hope for long-term HIV control without daily medication
|
First-in-human clinical trial of anti-PD1 medication for
people living with HIV confirms treatment safety and shows potential
for drug-free viral ... |
AbbVie's HIV Study: A Potential Game Changer in HIV Treatment
... Antiretroviral Therapy Undergoing Analytical Treatment Interruption. The study aims to assess changes in disease activity, adverse events, and ... View article...